GlobeMed Pharma Group offers a comprehensive portfolio of pharmaceutical-grade cannabinoid APIs, all produced under EU-GMP and Swiss-GMP certification and supported by complete analytical documentation, stability data, and Certificates of Analysis.
Our flagship Dronabinol API, Phytonabinol™, achieves 99.2% purity with validated stability, exceptional shelf life, and cost efficiency that surpasses synthetic alternatives. Supported by complete DMF and ASMF documentation, every batch reflects our commitment to transparency, reproducibility, and global pharmaceutical standards.
Each product is manufactured using advanced purification methods that guarantee reproducibility, safety, and compliance with global pharmaceutical frameworks.
Phytonabinol™ (Dronabinol API)
With the launch of Phytonabinol™, GlobeMed Pharma Group has redefined the standard for pharmaceutical-grade, plant-derived Dronabinol. Produced under EU-GMP and Swiss-GMP certification, Phytonabinol™ achieves an unprecedented 99.2% purity—uniting natural origin with true pharmaceutical precision. Backed by comprehensive Drug Master File (DMF) and Active Substance Master File (ASMF) documentation, it delivers full regulatory transparency, GMP traceability, and scalability for global commercial integration. Engineered for seamless incorporation into finished-dose formulations, clinical trial supply, and contract manufacturing, Phytonabinol™ embodies the next evolution of cannabinoid medicine—pure, compliant, and scientifically exact.
CBD (Cannabidiol) Isolate
Highly refined phytocannabinoid isolate offering 99%+ purity. Non-psychoactive and suitable for diverse therapeutic and research applications, including anti-inflammatory, anxiolytic, and neuroprotective formulations.
CBC (Cannabichromene) Isolate
A pharmaceutical-grade, plant-derived cannabinoid produced under EU-GMP and Swiss-GMP certification. Known for its non-psychoactive profile, CBC is being studied for its potential anti-inflammatory, neuroprotective, and mood-regulating properties. GlobeMed’s CBC Isolate offers ≥ 99% purity, batch-to-batch consistency, and full regulatory traceability, optimized for formulation in advanced therapeutic, cosmetic, and wellness applications.
CBG (Cannabigerol) Isolate
Known as the “stem cell” cannabinoid, CBG serves as a precursor to other cannabinoids. Our pharmaceutical-grade CBG isolate is ideal for R&D, anti-inflammatory, and antimicrobial formulations requiring ultra-high purity and consistency.
CBN (Cannabinol) Isolate
A mildly sedative cannabinoid known for its potential use in sleep aids and neuroprotective therapies. Produced under identical GMP controls for precise dosing and reproducibility.
THCV (Tetrahydrocannabivarin) Isolate
A rare cannabinoid with appetite-regulating, metabolic, and potential neuroprotective effects. Our THCV isolate is extracted and refined for pharmaceutical or advanced research use.
CannaFlavins A and B
Natural anti-inflammatory flavonoids exclusive to the cannabis plant, up to 30 times more potent than aspirin in COX-2 inhibition. Produced under GMP-compliant extraction and purification processes for integration into pain management and inflammation-focused product development.
Broad-Spectrum and Full-Spectrum Oils
Balanced cannabinoid matrices preserving natural ratios of cannabinoids and terpenes for advanced therapeutic applications, suitable for compounding and Magistral preparations.
Custom Formulations and White-Label Solutions
Tailored cannabinoid blends, extracts, and APIs designed to meet specific formulation, dosage, and regulatory requirements for global pharmaceutical and research partners.
Every batch. Every time. Verified purity, scientific precision, and proven consistency.